Page last updated: 2024-10-31

methylphenidate and HbS Disease

methylphenidate has been researched along with HbS Disease in 1 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daly, B1
Kral, MC1
Brown, RT1
Elkin, D1
Madan-Swain, A1
Mitchell, M1
Crosby, L1
Dematteo, D1
Larosa, A1
Jackson, S1

Trials

1 trial available for methylphenidate and HbS Disease

ArticleYear
Ameliorating attention problems in children with sickle cell disease: a pilot study of methylphenidate.
    Journal of developmental and behavioral pediatrics : JDBP, 2012, Volume: 33, Issue:3

    Topics: Adolescent; Anemia, Sickle Cell; Attention; Central Nervous System Stimulants; Child; Cognition; Dou

2012